Illumina, Inc. (ILMN)

Illumina to Acquire Grail for $8 billion, Shares Down Over 8%

Illumina Inc, a global leader in genomics, said on Monday that it would acquire Grail, a healthcare company whose mission is focused on early detection of multi-cancer, for cash and stock consideration of $8 billion.